Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine vs ropivacaine for brachial plexus block in shoulder arthroscopy
ChiCTR2400089999Phase 4Not yet recruiting
- Sponsor
- Guangzhou University of Chinese Medicine Third Affiliated Hospital
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bupivacaine in Rotator cuff deficiency (RCD) (2 arms), sponsored by Guangzhou University of Chinese Medicine Third Affiliated Hospital. Primary endpoint: Postoperative pain Visual Analogue Scale (VAS) score. Planned start Sep 2024; status: not yet recruiting.
02
Drugs
bupivacaine
03
Conditions
Rotator cuff deficiency (RCD)
Beyond the preview
Go deeper on ChiCTR2400089999.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400089999.